Are predictive factors clinically useful in bone marrow transplantation?
Variables that accurately predict the clinical outcome of any procedure, including bone marrow transplantation (BMT), are of paramount importance when assessing the risks and benefits of the procedure. This review of the world's literature of variables affecting overall outcome after myeloablative BMT critically appraises the value of many bone marrow transplant dogmas. There is a relative paucity of data supporting many commonly used transplant practices, including having an upper age limit for eligibility criteria, and absolute requirements for cardiac and pulmonary function pre transplant. In contrast, recently published literature suggests that several parameters occurring soon after a BMT has been performed may accurately predict transplant outcome. Ultimately, given the rapidly evolving nature of BMT, renewed clinical research of variables predictive of transplant outcome is needed.
Bolwell
B J
BJ
Department of Hematology and Medical Oncology, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D006086:Graft vs Host Disease / Q000209:etiology; D006334:Heart Function Tests; D006801:Humans; D019653:Myeloablative Agonists / Q000627:therapeutic use; D011379:Prognosis; D012129:Respiratory Function Tests; D016896:Treatment Outcome
D019653:Myeloablative Agonists